Physician profile
Ananth Kumar Arjunan
NPI 1194011924
$28,687.80
in general payments reported to CMS, 2019-2025
80 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,608 · 2020: $1,606 · 2021: $1,575 · 2022: $1,384 · 2023: $3,981 · 2024: $4,693 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,310 · Food and Beverage: $9,005 · Consulting Fee: $3,813 · Honoraria: $191 · Education: $110 · Travel and Lodging: $86.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,310.00 |
| Food and Beverage | $9,004.63 |
| Consulting Fee | $3,812.50 |
| Honoraria | $190.50 |
| Education | $110.07 |
| Travel and Lodging | $86.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $9,496.10 | 2019-2025 | Imfinzi, Enhertu, Calquence |
| Pfizer INC. | $4,801.33 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $1,921.42 | 2020-2025 | Imbruvica, Tecvayli, Darzalex |
| Janssen Biotech, INC. | $885.14 | 2019-2025 | Erleada, Rybrevant, Tecvayli |
| E.R. Squibb & Sons, L.L.C. | $851.61 | 2019-2025 | Opdivo |
| Merck Sharp & Dohme LLC | $571.10 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Beigene, LTD. | $525.00 | 2021 | |
| Gilead Sciences, INC. | $430.63 | 2019-2025 | Trodelvy |
| Novartis Pharmaceuticals Corporation | $420.09 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $417.07 | 2021-2025 | Libtayo |
| Rigel Pharmaceuticals, INC. | $400.61 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Medtronic, INC. | $362.68 | 2021-2023 | Osteocool Rf Ablation System |
| Athenex Pharmaceutical Division, LLC | $350.00 | 2020 | |
| Karyopharm Therapeutics INC. | $336.46 | 2021-2025 | Xpovio |
| Lilly USA, LLC | $333.94 | 2021-2025 | Retevmo, Verzenio, Jaypirca |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $333.54 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $311.76 | 2019-2025 | Fruzaqla, Ninlaro, Iclusig |
| Genzyme Corporation | $298.61 | 2019-2025 | |
| Pharmaessentia USA Corporation | $284.34 | 2023-2025 | Besremi |
| Astellas Pharma US INC | $265.36 | 2019-2025 | Xospata, Vyloy, Xtandi |
| Tempus Ai, INC | $248.72 | 2024-2025 | Xt Cdx |
| Abbvie INC. | $238.76 | 2020-2025 | |
| Celgene Corporation | $231.92 | 2024-2025 | Reblozyl |
| Glaxosmithkline, LLC. | $227.73 | 2020-2025 | Ojjaara, Jemperli, Shingrix |
| Amgen INC. | $224.09 | 2019-2023 | Kyprolis |
| Daiichi Sankyo INC. | $222.40 | 2020-2025 | Enhertu, Vanflyta, Injectafer |
| Novocure Gmbh | $200.00 | 2022 | |
| Incyte Corporation | $198.02 | 2019-2025 | Jakafi, Monjuvi |
| Eisai INC. | $195.00 | 2019-2025 | |
| Kite Pharma, INC. | $194.39 | 2020-2025 | Yescarta |
| Sirtex Medical INC | $162.18 | 2020-2025 | Sir-Spheres Microspheres |
| Array Biopharma INC | $155.99 | 2022-2025 | Braftovi, Mektovi, Xalkori |
| Caris Mpi, INC. | $148.43 | 2025 | Mi Cancer Seek |
| Blueprint Medicines Corporation | $138.39 | 2020-2025 | Ayvakit |
| Clovis Oncology, INC. | $136.05 | 2019-2020 | |
| Genentech USA, INC. | $129.95 | 2019-2025 | Polivy, Venclexta |
| Sobi, INC | $112.70 | 2023-2025 | |
| Tersera Therapeutics LLC | $98.69 | 2019-2025 | Xermelo |
| Servier Pharmaceuticals LLC | $96.38 | 2024-2025 | |
| Helsinn Therapeutics (U.S.), INC. | $96.19 | 2022 | |
| Seagen INC. | $94.74 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $91.24 | 2019-2025 | Onivyde, Somatuline Depot |
| Taiho Oncology, INC. | $85.33 | 2020-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $74.18 | 2019-2023 | Imbruvica, Epkinly |
| Dendreon Pharmaceuticals LLC | $73.11 | 2025 | Provenge |
| Agios Pharmaceuticals, INC. | $70.78 | 2024-2025 | Pyrukynd |
| Emd Serono, INC. | $67.97 | 2019-2024 | |
| Beone Medicines USA, INC. | $65.02 | 2025 | Brukinsa |
| Deciphera Pharmaceuticals INC. | $64.88 | 2023-2025 | Qinlock, Tgct |
| Alexion Pharmaceuticals, INC. | $63.82 | 2023-2025 | Ultomiris |
| Jazz Pharmaceuticals INC. | $63.70 | 2019-2024 | |
| Puma Biotechnology, INC. | $57.13 | 2020-2024 | |
| Mirati Therapeutics, INC. | $47.15 | 2024 | Krazati |
| Geron Corporation | $40.87 | 2025 | Rytelo |
| Secura Bio, INC. | $40.87 | 2024 | Copiktra |
| Dova Pharmaceuticals | $39.55 | 2020-2021 | |
| Stemline Therapeutics INC. | $39.15 | 2024-2025 | Orserdu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.21 | 2023-2025 | Gilotrif |
| Tesaro, INC. | $36.92 | 2019 | |
| Sun Pharmaceutical Industries INC. | $36.03 | 2020 | |
| Verastem, INC. | $31.48 | 2019 | |
| Adc Therapeutics America, INC. | $30.50 | 2024-2025 | |
| Emmaus Medical, INC. | $29.30 | 2023 | Endari |
| Beigene USA, INC. | $29.19 | 2024 | Brukinsa |
| Adaptive Biotechnologies Corporation | $29.06 | 2024 | Clonoseq |
| Immunomedics, INC. | $28.23 | 2020 | |
| Myriad Genetic Laboratories, INC. | $27.85 | 2025 | Myrisk |
| Genmab U.S., INC. | $26.60 | 2024 | Tivdak |
| Syndax Pharmaceuticals, INC. | $24.98 | 2025 | |
| Aveo Pharmaceuticals, INC. | $24.70 | 2025 | |
| Azurity Pharmaceuticals, INC. | $22.10 | 2025 | Danziten |
| Heron Therapeutics, INC. | $21.81 | 2019 | |
| Exelixis INC. | $20.63 | 2025 | Cabometyx |
| Morphosys, US INC. | $18.15 | 2023 | Monjuvi |
| Legend Biotech USA INC. | $17.16 | 2024 | |
| Pharmacosmos Therapeutics INC. | $17.12 | 2025 | Monoferric |
| Alnylam Pharmaceuticals INC. | $16.38 | 2024 | Givlaari |
| Kyowa Kirin, INC. | $15.63 | 2019 | |
| Acrotech Biopharma INC. | $14.51 | 2024 | Beleodaq |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ananth Arjunan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.